Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126271691 | 12627169 | 1 | I | 201103 | 20160729 | 20160805 | 20160805 | EXP | US-ASTRAZENECA-2016SE82769 | ASTRAZENECA | 636.00 | MON | F | Y | 0.00000 | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126271691 | 12627169 | 1 | PS | LISINOPRIL. | LISINOPRIL | 1 | Oral | U | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 2 | SS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | 0 | INJECTION | |||||||||
| 126271691 | 12627169 | 3 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | 0 | 1 | DF | CAPSULE | QD | |||||||
| 126271691 | 12627169 | 4 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 126271691 | 12627169 | 5 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 10 | MG | TABLET | TID | |||||||
| 126271691 | 12627169 | 6 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 300 | MG | CAPSULE | BID | |||||||
| 126271691 | 12627169 | 7 | C | CHLOROPHYLL | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 126271691 | 12627169 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | 1000 | IU | TABLET | QD | |||||||
| 126271691 | 12627169 | 9 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126271691 | 12627169 | 10 | C | EVEROLIMUS | EVEROLIMUS | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 126271691 | 12627169 | 11 | C | FISH OIL | FISH OIL | 1 | Oral | 0 | 1000 | MG | CAPSULE | QD | |||||||
| 126271691 | 12627169 | 12 | C | NOVOLOG | INSULIN ASPART | 1 | BEFORE EACH MEAL | 0 | |||||||||||
| 126271691 | 12627169 | 13 | C | LANTUS | INSULIN GLARGINE | 1 | INJECT 38 UNITS UNDER THE SKIN DAILY AT BEDTIME. | 0 | INJECTION | ||||||||||
| 126271691 | 12627169 | 14 | C | THERA-M | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 126271691 | 12627169 | 15 | C | ROXICODONE | OXYCODONE HYDROCHLORIDE | 1 | Oral | TAKE 1 TABLET (5 MG T AL) BY:MOUTH EVERY FOUR HOURS AS NEEDED | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 16 | C | DELTASONE | PREDNISONE | 1 | Oral | 1 TID X 2 DAYS | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 17 | C | DELTASONE | PREDNISONE | 1 | Oral | 1 BID X 2 DAYS | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 18 | C | DELTASONE | PREDNISONE | 1 | Oral | 1 QID X 2 DAYS | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 19 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | TAKE 10 MG BY MOUTH EVERY'SIX HOURS AS NEEDED | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 20 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | TAKE 10 MG BY MOUTH EVERY'SIX HOURS AS NEEDED | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 21 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | TAKE 1 TABLET (50 MG OTAL) BY MOUTH EVERY SIX HOURS AS NEEDED | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 22 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | TAKE BY MOUTH. 5 MG ON MON, THU; 7.5 MG ALL OTHER DAYS | 0 | TABLET | |||||||||
| 126271691 | 12627169 | 23 | C | INFLUENZA | INFLUENZA VIRUS VACCINE | 1 | 0 | ||||||||||||
| 126271691 | 12627169 | 24 | C | PNEUCOCCAL POLYSACCHARIDE | 2 | 0 | |||||||||||||
| 126271691 | 12627169 | 25 | C | TAMOXIFEN | TAMOXIFEN | 1 | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126271691 | 12627169 | 2 | Breast cancer stage IV |
| 126271691 | 12627169 | 15 | Pain |
| 126271691 | 12627169 | 19 | Nausea |
| 126271691 | 12627169 | 20 | Vomiting |
| 126271691 | 12627169 | 21 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126271691 | 12627169 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126271691 | 12627169 | Asthenia | |
| 126271691 | 12627169 | Breast cancer | |
| 126271691 | 12627169 | Disease progression | |
| 126271691 | 12627169 | Localised infection | |
| 126271691 | 12627169 | Metastases to bone | |
| 126271691 | 12627169 | Sciatica |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126271691 | 12627169 | 2 | 20151020 | 0 | ||
| 126271691 | 12627169 | 23 | 20160101 | 0 | ||
| 126271691 | 12627169 | 24 | 20150215 | 0 | ||
| 126271691 | 12627169 | 25 | 20150128 | 0 |